In 1998 was created BankInvest Biomedical Venture, which is appeared as VC.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Genmab, F2G, Nereus Pharmaceuticals. Among the most popular fund investment industries, there are Medical, Health Care.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the BankInvest Biomedical Venture, startups are often financed by Pacific Venture Group, Novartis Venture Fund, Gimv. The meaningful sponsors for the fund in investment in the same round are ODYSSEE VENTURE, Idinvest Partners, Dansk Erhvervsinvestering. In the next rounds fund is usually obtained by Sunstone Life Science Ventures, Novartis Venture Fund, Merifin Capital.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2019. This BankInvest Biomedical Venture works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2005. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies.
Related Funds
| Fund Name | Location |
| Accial Capital | Cambridge, Massachusetts, United States |
| Centre de Collaboration MiQro Innovation | - |
| Clear Channel Outdoor | New York, New York, United States |
| Crossfin Technology | Gauteng, NA - South Africa, South Africa |
| CTM insights | - |
| Curious Office Partners | Seattle, United States, Washington |
| Driscoll's | California, United States, Watsonville |
| Meili Finance | Beijing, Beijing, China |
| Mitsui Kinzoku-SBI Material Innovation Fund | - |
| Montreal Start Up | Canada, Montréal, Quebec |
| Pi Capital | England, London, United Kingdom |
| Point B Capital | Seattle, United States, Washington |
| Pollux Capital | Brazil, Rio, Rio de Janeiro |
| State of Wisconsin Investment Board | Madison, United States, Wisconsin |
| Sumin Investment | - |
| trivago | Düsseldorf, Germany, Nordrhein-Westfalen |
| Tuscan Ventures | India, Maharashtra, Mumbai |
| Wheatsheaf Group | Cheshire, Chester, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Resistentia Pharmaceuticals | $14M | 26 Sep 2006 | Uppsala, Uppsala County, Sweden | ||
Cellectis | $6M | 01 Jun 2005 | Paris, Ile-de-France, France | ||
LiPlasome Pharma | $8M | 01 Mar 2005 | Vejle, Region of Southern Denmark, Denmark | ||
Cellectis | $9M | 01 May 2002 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Resistentia Pharmaceuticals | $14M | 26 Sep 2006 | Uppsala, Uppsala County, Sweden | ||
Cellectis | $6M | 01 Jun 2005 | Paris, Ile-de-France, France | ||
LiPlasome Pharma | $8M | 01 Mar 2005 | Vejle, Region of Southern Denmark, Denmark | ||
Cellectis | $9M | 01 May 2002 | Paris, Ile-de-France, France |
